Meeting Program

To view program in "24 hour" time (international) click here.

Friday, February 11
3:00 - 7:30 PM	Registration	Van Horne Foyer
6:30 - 7:30 PM	Refreshments	Van Horne Foyer
7:30 - 9:30 PM	Keynote Session (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom
	Victor R. Ambros, University of Massachusetts, USA Functions of MicroRNAs in Animal Development
	Scott W. Lowe, Cold Spring Harbor Laboratory, USA Talk Title to be Determined
Saturday, February 12
7:00 - 8:00 AM	Breakfast	Mezzanine 2
8:00 - 11:00 AM	MicroRNA Mechanisms (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom
	Phillip D. Zamore, University of Massachusetts Medical School, USA Germline and Somatic Small RNAs
	Elisa Izaurralde, MPI for Developmental Biology, Germany Mechanisms of microRNA Action
	Gunter Meister, Max Planck Institute for Biochemistry, Germany Regulation of Argonaute Function
	John L. Rinn, Beth Israel Deaconess Medical Center, USA Large Intergenic Non-Coding RNAs: From Discovery to Mechanism
	Short Talk(s) to be Chosen from Abstracts,
9:20 - 9:40 AM	Coffee Break	Van Horne Foyer
11:00 AM- 1:00 PM	Poster Setup	Mezzanine 2
1:00 - 10:00 PM	Poster Viewing	Mezzanine 2
4:30 - 5:00 PM	Coffee Available	Van Horne Foyer
5:00 - 7:00 PM	MicroRNA Targets and Polymorphisms (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom
	Nikolaus Rajewsky, Max Delbruck Center for Molecular Medicine, Germany Talk Title to be Determined
	Robert B. Darnell, HHMI/Rockefeller University, USA Identifying MicroRNA Targets
	Karen P. Steel, Wellcome Trust Genome Campus, UK The Role of miRNA Mutations in Mendelian Disease
	Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Mezzanine 2
7:30 - 10:00 PM	Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Mezzanine 2
Sunday, February 13
7:00 - 8:00 AM	Breakfast	Mezzanine 2
8:00 - 11:00 AM	MicroRNAs in Muscle Development and Disease Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom B
	Eric N. Olson, University of Texas Southwestern Medical Center at Dallas, USA MicroRNA Control of Muscle Disease and Development
	Gerald Dorn, Washington University School of Medicine, USA Genetic Variation and microRNA Targeting of Cardiac mRNAs
	Thomas Thum, Medical School Hannover, Germany MicroRNA Function in Heart Disease
	William T. Pu, Children's Hospital, Boston, USA MicroRNA Regulation of Gene Expression in the Heart
	Short Talk(s) to be Chosen from Abstracts,
Following Session is for RNAs and Cancer (J5)
8:00 - 11:00 AM	MicroRNAs as Oncogenes and Tumor Suppressors I Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom C
	Phillip A. Sharp, Massachusetts Institute of Technology, USA Small RNA-Guided Gene Silencing and Its Therapeutic Potential
	Lin He, University of California, Berkeley, USA MicroRNAs in the p53 Pathway
	Martine F. Roussel, St. Jude Children's Research Hospital, USA MicroRNAs in Nervous System Malignancies
	Varda Rotter, Weizmann Institute of Science, Israel MicroRNAs in Neoplastic Transformation of Human Cells
9:20 - 9:40 AM	Coffee Break	Van Horne Foyer
11:00 AM- 1:00 PM	Poster Setup	Mezzanine 2
1:00 - 10:00 PM	Poster Viewing	Mezzanine 2
4:30 - 5:00 PM	Coffee Available	Van Horne Foyer
5:00 - 7:00 PM	MicroRNAs and Vascular Disease Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom B
	Stefanie Dimmeler, University of Frankfurt, Germany Control of Angiogenesis by MicroRNA
	Thomas Braun, Max Planck Institute for Heart and Lung Research, Germany The Role of MicroRNAs in Atherosclerosis
	Chunxiang Zhang, University of Medicine and Dentistry of New Jersey, USA MicroRNAs and Vascular Remodeling
	Short Talk to be Chosen from Abstracts,
Following Session is for RNAs and Cancer (J5)
5:00 - 7:00 PM	MicroRNAs as Oncogenes and Tumor Suppressors II Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom C
	Joshua Mendell, Johns Hopkins University, USA Mechanisms and Consequences of MicroRNA Dysregulation in Cancer
	Andrea Ventura, Memorial Sloan-Kettering Cancer Center, USA MicroRNA Oncogenes
	Carlo M. Croce, Ohio State University, USA MicroRNAs and Cancer
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Mezzanine 2
7:30 - 10:00 PM	Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Mezzanine 2
Monday, February 14
7:00 - 8:00 AM	Breakfast	Mezzanine 2
8:00 - 11:00 AM	MicroRNAs in CNS Disorders Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom B
	Gerhard Schratt, University of Heidelberg, Germany MicroRNA Regulation of Dendritic and Synaptic Plasticity
	Bart De Strooper, Center for Human Genetics, Belgium MicroRNAs in Alzheimer's Disease
	Beverly L. Davidson, University of Iowa, USA Noncoding RNAs and Huntington's Disease
	Claes Wahlestedt, The Scripps Research Institute, USA Natural Antisense Transcripts and microRNAs in Neuroscience
	Short Talk(s) to be Chosen from Abstracts,
Following Session is for RNAs and Cancer (J5)
8:00 - 11:00 AM	MicroRNAs in the Immune Response, Angiogenesis and Metastasis Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom C
	David Baltimore, California Institute of Technology, USA MicroRNAs in the Immune System
	Speaker to be Announced,
	Sohail F. Tavazoie, Rockefeller University, USA Regulation of Cancer Metastasis by Human MicroRNAs
	Chi Van Dang, Johns Hopkins University School of Medicine, USA MicroRNAs, the Myc Pathway and Tumor Microenvironment
	Short Talks to be Chosen from Abstracts, ,
9:20 - 9:40 AM	Coffee Break	Van Horne Foyer
11:00 AM- 1:00 PM	Poster Setup	Mezzanine 2
1:00 - 10:00 PM	Poster Viewing	Mezzanine 2
4:30 - 5:00 PM	Coffee Available	Van Horne Foyer
5:00 - 7:00 PM	MicroRNAs in the Immune Response and Viral Infections Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom B
	Peter Sarnow, Stanford University School of Medicine, USA Modulation of Hepatitis C Virus by MicroRNA-122
	Stephane Heymans, Maastricht University, Netherlands Inflammation-MicroRNAs and Cardiac Disease
	Bryan R. Cullen, Duke University Medical Center, USA Viruses and MicroRNAs
	Short Talk to be Chosen from Abstracts,
Following Session is for RNAs and Cancer (J5)
5:00 - 7:00 PM	MicroRNAs as Cancer Biomarkers Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom C
	Curtis C. Harris, NCI, National Institutes of Health, USA MicroRNAs and Inflammatory Cytokines as Biomarkers and Diagnosis, Prognosis and Therapeutic Outcomes
	Frank J. Slack, Yale University, USA MicroRNAs as Diagnostics and Therapeutics in Cancer
	Xin Wei Wang, NCI, National Institutes of Health, USA Liver Cancer, MicroRNA and Sensitivity to Interferon Therapy
	Short Talks to be Chosen from Abstracts, ,
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Mezzanine 2
7:30 - 10:00 PM	Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Mezzanine 2
Tuesday, February 15
7:00 - 8:00 AM	Breakfast	Mezzanine 2
8:00 - 11:00 AM	MicroRNAs and Stem Cells (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom
	Gregory J. Hannon, Cold Spring Harbor Laboratory, USA MicroRNAs in Mammary Epithelial Stem/Progenitors and Tumor-Initiating Cells
	Scott M. Hammond, University of North Carolina at Chapel Hill, USA Talk Title to be Determined
	Deepak Srivastava, Gladstone Institute of Cardiovascular Disease, USA MicroRNA Regulation of Cardiac Cell Fate and Morphogenesis
	Robert H. Blelloch, University of California, San Francisco, USA MicroRNA Regulation of ES Cell Self-Renewal and Differentiation
	Short Talk(s) to be Chosen from Abstracts,
9:20 - 9:40 AM	Coffee Break	Van Horne Foyer
2:30 - 4:30 PM	Workshop: MicroRNA Therapeutics: Medicinal Chemistry and Delivery (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom
	Jesper Wengel, University of Southern Denmark, Denmark LNA (Locked Nucleic Acid) and UNA (Unlocked Nucleic Acid)
	Muthiah Manoharan, Alnylam Pharmaceuticals, Inc., USA Medicinal Chemistry and Delivery of siRNAs and Antagomirs
	David R. Corey, University of Texas Southwestern Medical Center, USA Unusual Targets for Duplex RNAs
	Short Talks to be Chosen from Abstracts, ,
4:30 - 5:00 PM	Coffee Available	Van Horne Foyer
5:00 - 7:00 PM	MicroRNA Therapeutics: Applications (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 01/11/2011	Van Horne Ballroom
	Sakari Kauppinen, Santaris Pharma, Denmark Targeting MicroRNAs for Therapeutics
	Eva van Rooij, Miragen Therapeutics, USA Therapeutic Regulation of MiRNAs to Treat Cardiovascular Disease
	Markus Stoffel, Institut f. Molekulare Systembiologie, Switzerland Mechanisms for Lipophile Oligonucleotide Biodistribution
	Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM	Social Hour w/ Lite Bites	Mezzanine 2
8:00 - 11:00 PM	Entertainment	Mezzanine 2
Wednesday, February 16
	Departure
*=Session Chair     †=Speaker invited, not yet responded.

MicroRNAs have emerged as key regulators of numerous diseases including cancer, heart disease, neurological disorders and vascular abnormalities. This meeting will bring together international leaders in the field of microRNA biology and its relationship to human disease. Because the meeting will be concurrent with the Keystone meeting on non-coding RNAs and cancer, we will focus on diseases other than cancer. There will be combined plenary sessions focusing on microRNA mechanisms of action and the identification of microRNA targets. Subsequent sessions will cover the latest advances on the roles of microRNAs in stem cells, cardiovascular, muscle, infectious, and neurological diseases. The meeting will conclude with combined sessions on recent advances in microRNA therapeutics.